# Preventing Brain Injury in Infants With Congenital Heart Disease

> **NCT01426542** · PHASE1 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 24 (actual)

## Conditions studied

- Cyanotic Congenital Heart Disease

## Interventions

- **DRUG:** Topiramate
- **OTHER:** No medication, but routine heart surgery

## Key facts

- **NCT ID:** NCT01426542
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2017-07-28
- **Final completion:** 2017-07-28
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426542

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426542, "Preventing Brain Injury in Infants With Congenital Heart Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01426542. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*